Scientists have discovered that an active, rather than passive, process dictates which nanoparticles enter solid tumours. The finding upends previous thinking in the field of cancer nanomedicine and points toward more effective nanotherapies.
Tuesday, January 14, 2020
Most engineered nanoparticles enter tumours through cells, not between them
Scientists have discovered that an active, rather than passive, process dictates which nanoparticles enter solid tumours. The finding upends previous thinking in the field of cancer nanomedicine and points toward more effective nanotherapies.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment